iVeena Delivery Systems Completes Phase 1/2a Pilot Clinical Study of IVMED-10 for Post-Cataract Inflammation
SALT LAKE CITY--(BUSINESS WIRE)--iVeena completes initial safety clinical study of IVMED-10, a therapy that treats front and back of the eye inflammation after cataract surgery